Sari H. Pakkanen

Sari H. Pakkanen

Auto-generated profile, based on publicly available information

Sari H. Pakkanen

Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2015 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
AKAnu Kantele
Anu Kantele
TLTinja Lääveri
Tinja Lääveri
SMSointu Mero
Sointu Mero
KVKatri Vilkman
Katri Vilkman
SPSari H. Pakkanen
Sari H. Pakkanen
JKJuha Kirveskari
Juha Kirveskari
Background. More than 300 million travelers visit regions with poor hygiene annually. A significant percentage of them become colonized by resistant intestinal bacteria such as extended-spectrum beta-lactamase–producing Enterobacteriaceae (ESBL-PE) and may transmit the strains to others and to medical care settings when they return home. Despite the threats to global healthcare caused by an upsurge in antimicrobial resistance, no effort has been centered on prevention of colonization while traveling. Methods. Stool samples were collected from 430 Finns before and after traveling outside Scandinavia. All specimens were analyzed for ESBL- and carbapenemase-producing Enterobacteriaceae (CPE). Questionnaires were used to survey volunteers about use of antimicrobials as well as other potential risk factors. The results were subjected to multivariable analysis. Results. Twenty-one percent (90/430) of the travelers became colonized by ESBL-PE and none by CPE. Geographic region, occurrence of travelers' diarrhea (TD), age, and use of antimicrobial (AB) for TD were identified as independent risk factors predisposing to contracting ESBL-PE. Eleven percent of those in subgroup TD−AB−, 21% in TD+AB−, and 37% in TD+AB+ acquired ESBL-PE. The risk proved to be highest in South Asia (46%); 23% became colonized in subgroup TD−AB−, 47% in TD+AB−, and 80% in TD+AB+. In Southeast Asia, the rates were 14%, 37%, and 69%, respectively. Conclusions. TD and antimicrobials for TD proved to be independent risk factors, with up to 80% of TD+AB+ travelers contracting ESBL-PE. In modern pre-travel counseling for those visiting high-risk regions, travelers should be advised against taking antibiotics for mild or moderate TD.

1 July 2006 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
HJHannu Järveläinen
Hannu Järveläinen
PPPauli Puolakkainen
Pauli Puolakkainen
SPSari Pakkanen
Sari Pakkanen
EBEric L. Brown
Eric L. Brown
MHMagnus Höök
Magnus Höök
TWThomas Wight
Thomas Wight

13 July 2016 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
KVKatri Vilkman
Katri Vilkman
SPSari H. Pakkanen
Sari H. Pakkanen
TLTinja Lääveri
Tinja Lääveri
HSHeli Siikamäki
Heli Siikamäki
AKAnu Kantele
Anu Kantele
The annual number of international tourist arrivals has recently exceeded one billion, yet surprisingly few studies have characterized travelers’ behavior, illness, and risk factors in a prospective setting. Particularly scarce are surveys of data spanning travel, return, and follow-up of the same cohort. This study examines behavior and illness among travelers while abroad, after return home, and at follow-up. Patterns of behavior connected to type of travel and illness are characterized so as to identify risk factors and provide background data for pre-travel advice. Volunteers to this prospective cohort study were recruited at visits to a travel clinic prior to departure. Data on the subjects’ health and behavior were collected by questionnaires before and after journeys and over a three-week follow-up. In addition, the subjects were asked to fill in health diaries while traveling. The final study population consisted of 460 subjects, 79 % of whom reported illness during travel or on arrival: 69 % had travelers’ diarrhea (TD), 17 % skin problems, 17 % fever, 12 % vomiting, 8 % respiratory tract infection, 4 % urinary tract infection, 2 % ear infection, 4 % gastrointestinal complaints other than TD or vomiting, and 4 % other symptoms. Of all subjects, 10 % consulted a doctor and 0.7 % were hospitalized; 18 % took antimicrobials, with TD as the most common indication (64 %). Ongoing symptoms were reported by 25 % of all travelers upon return home. During the three-week follow-up (return rate 51 %), 32 % of respondents developed new-onset symptoms, 20 % visited a doctor and 1.7 % were hospitalized. Factors predisposing to health problems were identified by multivariable analysis: certain regions (Southern Asia, South-Eastern Asia, and Eastern Africa), female gender, young age, and long travel duration. Despite proper preventive measures like vaccinations, malaria prophylaxis, and travel advice, the majority of our subjects fell ill during or after travel. As the symptoms mostly remained mild, health care services were seldom needed. Typical traveler profiles were identified, thereby providing a tool for pre-travel advice. The finding that one third reported new-onset illness during follow-up attests to the importance of advising clients on potential post-travel health problems already during pre-travel visits.

1 March 2010 in Clinical and Vaccine Immunology
Verified
Journal Article
Closed access
SPSari H. Pakkanen
Sari H. Pakkanen
JKJussi M. Kantele
Jussi M. Kantele
ZMZina Moldoveanu
Zina Moldoveanu
SHSpencer Hedges
Spencer Hedges
MHMiikka HäkKinen
Miikka HäkKinen
AKAnu Kantele
Anu Kantele
Although secretory IgA is the most abundantly produced Ig isotype, the mechanisms underlying the differential distribution of IgA subclasses in various body fluids remain unclear. To explore these mechanisms, we examined the distribution of IgA subclasses, the influence of the nature and sites of encounters with antigens, and the correlation between IgA subclass distribution and homing potentials of circulating IgA plasmablasts. IgA1 predominated in serum, tears, nasal wash fluid, and saliva; the levels of IgA1 and IgA2 were comparable in vaginal wash fluid; and IgA2 predominated in intestinal lavage fluids. Seventy-one percent of circulating IgA plasmablasts secreted IgA1. The intestinal homing receptor (HR), α4β7, was expressed more frequently on IgA2 than on IgA1 plasmablasts, with no differences in the expression of other HRs. IgA subclass distribution among circulating antigen-specific antibody-secreting cells (ASC) was dependent on the nature of the antigen: following vaccination withSalmonella entericaserovar Typhi, unconjugated pneumococcal polysaccharide, orHaemophilus influenzaepolysaccharide-diphtheria toxoid conjugate, the proportions of specific IgA1 ASC were 74%, 47%, 56%, and 80%, respectively. HR expression depended on the route of administration: expression of HRs was different after oral than after parenteral vaccination, while no difference was seen between HR expression of antigen-specific IgA1 and IgA2 ASC induced via the same route. The key factors determining IgA subclass distribution in a given secretion are the nature of the antigens encountered at a particular site and the site-specific homing instructions given to lymphocytes at that site. These two factors are reflected as differences in the homing profiles of the total populations of circulating IgA1 and IgA2 plasmablasts.

7 March 2006 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
IKIlpo Koskivirta
Ilpo Koskivirta
OROtto Rahkonen
Otto Rahkonen
MMMikko Mäyränpää
Mikko Mäyränpää
SPSari Pakkanen
Sari Pakkanen
MHMichael Husheem
Michael Husheem
HJHannu Järveläinen
Hannu Järveläinen

1 October 2013 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
JAJenni Antikainen
Jenni Antikainen
AKAnu Kantele
Anu Kantele
SPSari H. Pakkanen
Sari H. Pakkanen
TLTinja Lääveri
Tinja Lääveri
JRJukka Riutta
Jukka Riutta
JKJuha Kirveskari
Juha Kirveskari